author-photo

Martin Sebastian

Goethe University Frankfurt
University of Mainz

204

Papers

6077

Citations

Citation Trend

Filter By

Papers (204) Sort By

JournalConferenceOthers

The Impact of Renal Impairment on 30-day Outcomes Following Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndromes

2021 Heart Lung and Circulation
Show All
- Source
- Cite
- Save
Citations (0)
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer:

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock in the Post-SHOCK II Trial Era

2021 Heart Lung and Circulation
- Tie E. Nan
- Diem Dinh
- David J. Clark
- A Ajani
- Angela Brennan
- N. Cohen
- M. Dagan
- J. Shaw
- Martin Sebastian
- Melanie Freeman
- Ernesto Oqueli
- C. Reid
- David M. Kaye
- Dion Stub
- S Duffy
Show All
- Source
- Cite
- Save
Citations (0)
1655P Real-world outcome of patients with relapsed or refractory small cell lung cancer treated with checkpoint inhibitors in Tertiary Care Centers across Germany

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Too Good to be True

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
186TiP An open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1309P A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号